Robots from Stryker and Zimmer Biomet are worth a look.
Financial advisers must adapt their business if they want to appeal to the younger generations, says Kind Wealth's David O'Leary.
What does 2020 have in store for year-end?
November's U.S. election results and favorable vaccine news help reverse the fortunes of downtrodden small-cap and value stocks.
Financial advisers are having to adapt to a new digital world. Carl Richards, creator of the Behavior Gap, looks at the challenges IFAs face and how to overcome them.
We're at an inflection point in ESG investing, says Sustainalytics founder Michael Jantzi. Here's why.
Watch our analysts debate whether Milton Friedman's views hold up.
We think these two retail stocks are in the bargain bin.
The legendary pony takes on Tesla and aims for pole position on profitability.
Here's how they've been performing and what college savers should be thinking about today.
Don't eat that first potato chip.
And do any other assets currently compare?
Their shares have gotten hammered this year. Are they opportunities or value traps?
Where to look when your portfolio needs a shift.
Our new rating highlights the degree to which a fund or asset manager considers environmental, social, and governance issues.
Our analysts are excited about these names.
How to approach open enrollment season with this in mind.
Morningstar's Alex Bryan spotlights two funds where the risks outweigh the rewards.
If it's yield you're looking for, Morningstar's Alex Bryan has some recommendations.
A portfolio that tilts toward gold and equities.
Investing your HSA assets is really the way to maximize the tax benefits.
These Morningstar Medalists' returns are near the bottom of their categories this year.
A year after Morningstar introduced its enhanced fund rating methodology, a look at some of the effects.
These Morningstar Medalists' returns are near the top of their respective categories in 2020.
A discussion of taxes, stimulus, regulation, and the likely market reaction as we get results.
The electric car pioneer is ramping up production. Here's what we think it's worth.
Resist the urge to let predictions affect your portfolio.
Here's some advice for those tempted to tinker with their portfolios during times of market turbulence.
What would decriminalization in the U.S. do to established marijuana producers across the border? We ask Kristoffer Inton about opportunities available today.
Rolls-Royce has had a difficult time in recent years and recently announced a capital-raising. Morningstar analyst Joachim Kotze looks at the prospects for the business.
Benchmark construction is not as mechanical as you might think.
We discuss whether a fund manager's ownership stake in his or her fund says anything about its prospects.
Hear from our 2020 Outstanding Portfolio Manager Award winner.
These names stand to benefit from a resumption of leisure travel -- and are all trading below our fair value estimates.
Morningstar Rising Talent award winner Mohit Mittal discusses how the coronavirus may impact the economy in 2021.
See what we like about Pioneer National Resources.
Here is our doorway to 529 plans, one of the most often used college savings plans.
What we see in this low-yield environment.
They have withstood the coronavirus in ways other REITs have not.
Why does it happen, and what steps can you take?
And what we expect from October.
And four companies we like right now.
When will crude oil recover?
In the somewhat frothy consumer defensive sector, alcoholic beverage producers look cheap.
Policies for financial advice, 401(k)s, and more can take a turn depending on results.
New research from Morningstar unpacks the different ways exchange-traded funds pursue sustainable investing.
As that time of the year approaches, our experts discuss what investors should anticipate.
Take stock of your spending to determine if inflation is an issue for you.
Investors who have the wherewithal should consider fully funding their health savings accounts.